Citius Oncology (CTOR) Stock Chart & Stock Price History $1.97 +0.02 (+1.03%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.98 +0.01 (+0.51%) As of 07/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Citius Oncology Stock Price Performance The Citius Oncology (CTOR) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 71.30%. In the past month, the stock has decreased 43.71%, reflecting recent market activity. As of the latest close, Citius Oncology traded at $1.97 with a market cap of $154.39 million and volume of 2.28 million shares. Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+33.11%1 Month Performance-43.71%3 Month Performance+170.23%Year-To-Date Performance+71.30% CTOR Stock Chart for Saturday, July, 26, 2025 CTOR Chart by TradingView Citius Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$1.95$1.97+1.03%$2.38$1.952.28 million shs$154.39 million07/24/2025$1.82$1.95+7.14%$1.99$1.811.13 million shs$152.82 million07/23/2025$1.65$1.82+10.30%$2.84$1.7019.53 million shs$142.64 million07/22/2025$1.48$1.65+11.49%$1.70$1.47432,580 shs$118.06 million07/21/2025$1.53$1.48-3.27%$1.59$1.47342,255 shs$105.89 million07/18/2025$1.60$1.53-4.38%$1.72$1.52573,376 shs$109.47 million07/17/2025$1.57$1.60+1.91%$1.76$1.551.15 million shs$114.48 million07/16/2025$1.54$1.57+1.95%$1.82$1.3516.17 million shs$112.33 million07/15/2025$1.94$1.54-20.62%$2.09$1.541.40 million shs$110.19 million07/14/2025$2.82$1.94-31.21%$2.66$1.81967,101 shs$138.81 million Get the Latest News and Ratings for CTOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$3.25$2.82-13.23%$3.20$2.82541,959 shs$201.77 million07/10/2025$4.34$3.25-25.12%$4.28$3.00873,065 shs$232.54 million07/09/2025$4.26$4.34+1.88%$4.56$4.11244,533 shs$310.53 million07/08/2025$4.71$4.26-9.55%$4.80$4.14262,552 shs$304.80 million07/07/2025$5.32$4.71-11.47%$5.24$4.60544,120 shs$337.01 million07/04/2025$5.32$5.32$5.89$4.90647,470 shs$380.66 million07/03/2025$5.22$5.32+1.92%$5.89$4.90647,470 shs$380.65 million07/02/2025$5.19$5.22+0.58%$5.44$4.73748,606 shs$373.49 million07/01/2025$4.35$5.19+19.31%$5.45$4.251.47 million shs$371.34 million06/30/2025$4.50$4.35-3.33%$4.86$4.061.18 million shs$311.24 million06/27/2025$3.50$4.50+28.57%$6.19$3.5211.49 million shs$321.98 million06/26/2025$2.76$3.50+26.81%$3.52$2.661.70 million shs$250.43 million06/25/2025$2.66$2.76+3.76%$2.99$2.438.38 million shs$197.48 million Related Companies Kamada Stock Chart Erasca Stock Chart Aquestive Therapeutics Stock Chart Compass Therapeutics Stock Chart Fulcrum Therapeutics Stock Chart REGENXBIO Stock Chart Tectonic Therapeutic Stock Chart MBX Biosciences Stock Chart SNDL Stock Chart COMPASS Pathways Stock Chart Receive CTOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTOR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIt’s my duty to share the “truth” I see behind this bible verseFormer CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTOR Stock Alerts